1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ALIVUS LIFE SCIENCES LTD.

Alivus Life Sciences Ltd. NSE: ALIVUS | BSE: 543322

Alivus Life Sciences Ltd. Live Share Price Today, Share Analysis and Chart

Expensive Performer
Download real time

1028.10 4.20 (0.41%)

38.21% Gain from 52W Low

48,225 NSE+BSE Volume

NSE 23 Apr, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
Medium Financial Strength
45.0 / 100
Valuation Score
Expensive Valuation
29.7 / 100
Momentum Score
Technically Neutral
40.5 / 100
Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM
Analyst Price Target
1,296
1Yr Price target upside is 26%
4 analysts

12

S

6

W

5

O

4

T

SWOT Analysis

Alivus Life Sciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

23 Jan, 2025 BSE INDIA
Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Ana…
Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Ana…
pdf link
25 Oct, 2024 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-A…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-A…
pdf link
25 Oct, 2024 TRENDLYNE
Glenmark Life Sciences Results Earnings Call for Q2FY25
Glenmark Life Sciences Results Earnings Call for Q2FY25
video link
02 Aug, 2024 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-E…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-E…
pdf link AI Summary
27 Jul, 2024 TRENDLYNE
Glenmark Life Sciences Results Earnings Call for Q1FY25
Glenmark Life Sciences Results Earnings Call for Q1FY25
audio video link
26 Jul, 2024 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-A…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-A…
pdf link
03 May, 2024 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-E…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-E…
pdf link AI Summary
26 Apr, 2024 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-A…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-A…
pdf link
25 Apr, 2024 TRENDLYNE
Glenmark Life Sciences Results Earnings Call for Q4FY24
Glenmark Life Sciences Results Earnings Call for Q4FY24
audio video link
31 Jan, 2024 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-E…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-E…
pdf link
24 Jan, 2024 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-A…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-A…
pdf link
24 Jan, 2024 TRENDLYNE
Glenmark Life Sciences Results Earnings Call for Q3FY24
Glenmark Life Sciences Results Earnings Call for Q3FY24
audio video link
All Earnings Calls
Annual Report Mar-2024
pdf
Annual Report Mar-2023
pdf
Annual Report Mar-2022
pdf
25 May, 2022 INDIA RATINGS
India Ratings Affirms Glenmark Life Sciences at IND AA-/Stable
link
23 Jan, 2025 BSE INDIA
Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Inv…
Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Inv…
pdf link
24 Oct, 2024 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
pdf link
25 Jul, 2024 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
pdf link
25 Apr, 2024 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
pdf link
11 Mar, 2024 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
pdf link
23 Jan, 2024 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
pdf link
20 Oct, 2023 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
pdf link
21 Jul, 2023 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
pdf link
27 Apr, 2023 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
pdf link
27 Jan, 2023 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
pdf link
17 Nov, 2022 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
pdf link
17 Nov, 2022 BSE INDIA
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…
pdf link

Alivus Life Sciences Ltd. FAQ

How is Alivus Life Sciences Ltd. today?
Alivus Life Sciences Ltd. today is trading in the green, and is up by 0.41% at 1028.10.
Alivus Life Sciences Ltd. is currently trading up 0.41% on an intraday basis. In the past week the stock rose 3.68%. stock has been down -8.42% in the past quarter and rose 22.46% in the past year. You can view this in the overview section.